RO7062931

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RO7062931, covering 2020-08-03 to 2020-12-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of RO7062931in Healthy Volunteers and Subjects With Chronic Hepatitis B [Phase 1]

See pricing